Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
BRAF V600 metastatic melanoma
.
Show all posts
Showing posts with label
BRAF V600 metastatic melanoma
.
Show all posts
Wednesday, August 8, 2012
Kinase Inhibitor Trials Show Melanoma Benefits | News | Drug Discovery and Development Magazine
›
Findings from GlaxoSmithKline (GSK) plc’s Phase 3 clinical study program evaluating single agent therapy with the targeted anti-cancer ag...
›
Home
View web version